公司要闻： 国邦医药（605507）：公司发布公告，公司拟对董事、高管在内的270名员工实施员工持股计划，拟筹 集资金总额不超过1.85 亿元，涉及的股票总数不超过股本总额的10%，存续期为24 个月，锁定期为12 个月。 泰恩康（301263）：公司发布公告，子公司山东华铂凯盛于近日收到国家药品监督管理局签发的巴瑞替 尼片《药品注册证书》，经审查，本品符合药品注册的有关要求，批准注册。 一品红（300723）：公司发布公告，子公司广州一品红于近日收到国家药品监督管理局核准签发的艾司 奥美拉唑镁肠溶干混悬剂《药品注册证书》，，经审查，本品符合药品注册的有关要求，批准注册。 恩华药业（002262）：公司发布公告，近日收到国家药品监督管理局签发的盐酸羟考酮缓释片《药品注 册证书》，经审查，本品符合药品注册的有关要求，批准注册。 市场表现： 2025 年11 月28 日，医药板块涨跌幅+0.14%，跑输沪深300 指数0.11pct，涨跌幅居申万31 个子行业第27 名。各医药子行业中，医疗设备(+1.53%)、医院（+0.95%)、其他生物制品(+0.70%)表现居前，线下药 店（-0.55%）、疫苗(-0.4 ...

Core Viewpoint - Jiangsu Pacific Quartz Co., Ltd. has successfully elected its sixth board of directors and appointed key management personnel, ensuring compliance with relevant laws and regulations [1][4][12]. Group 1: Election of the Sixth Board of Directors - The sixth board of directors was elected during the first extraordinary general meeting held on November 28, 2025, with a total of 5 non-independent directors and 3 independent directors elected [38]. - Li Wei was elected as the employee representative director, joining the newly formed board [1][38]. - The term of the new board is set for three years, starting from the date of approval at the extraordinary general meeting [38]. Group 2: Management Appointments - Chen Shibin was elected as the chairman of the sixth board of directors and appointed as the general manager, with a term aligned with the board [20][39]. - Other key appointments include: - Fang Tingting as the board secretary - Zhang Liwen as the financial officer - Liu Mingwei as the deputy general manager - Zhou Mingqiang as the chief engineer - Li Xingdi as the securities representative - Zhao Shijiang as the internal audit manager [39][40][41]. Group 3: Compliance and Legal Assurance - The company confirmed that all election and appointment procedures adhered to the Company Law and relevant regulations, ensuring the legality and validity of the resolutions passed [10][12][40]. - The qualifications of the newly appointed management personnel were reviewed and found to meet the necessary legal and regulatory standards [41].

太平洋酒吧(08432)公布截至2025年9月30日止六个月的中期业绩，收益约1.03亿港元，同比增长5.4%;公 司拥有人应占溢利719.4万港元，同比扭亏为盈;每股盈利0.83港仙。 ...

智通财经APP讯，太平洋酒吧(08432)公布截至2025年9月30日止六个月的中期业绩，收益约1.03亿港 元，同比增长5.4%;公司拥有人应占溢利719.4万港元，同比扭亏为盈;每股盈利0.83港仙。 ...

太平洋航运(02343)发布公告，于2025年11月28日注销1789.9万股已回购股份。 ...

智通财经APP讯，太平洋航运(02343)发布公告，于2025年11月28日注销1789.9万股已回购股份。 ...

格隆汇11月28日丨太平洋航运(02343.HK)发布公告，2025年11月28日注销1789.9万股购回股份。 ...

Group 1 - The 2025 Analyst Conference and the 7th Sina Finance "Golden Unicorn" Best Analyst Awards Ceremony took place on November 28, gathering over 300 authoritative scholars, public and private fund leaders, listed company chairpersons, top fund managers, and chief analysts in Shanghai to discuss future opportunities in the Chinese capital market [1] - The results of the 7th Sina Finance Golden Unicorn Best Analyst selection were announced [2] Group 2 - The top analysts in the non-bank financial sector were recognized, with the following rankings: 1. Guotai Junan Securities Research Team (Chief Analyst: Liu Xinqi) 2. GF Securities Research Team (Chief Analyst: Chen Fu) 3. Huachuang Securities Research Team (Chief Analyst: Xu Kang) 4. Dongwu Securities Research Team (Chief Analyst: Sun Ting) 5. Industrial Securities Research Team (Chief Analyst: Xu Yizhou) 6. Guojin Securities Research Team (Chief Analyst: Xia Changsheng) 7. Changjiang Securities Research Team (Chief Analyst: Wu Yifan) [3]

同时，西太平洋银行预计生产率将出现显著反弹，全年增幅达0.9%，这将推动名义单位劳动力成本增 速放缓至约2.5%（按六个月年化计算）。这对正在权衡通胀前景的澳洲联储而言将是一个积极信号。 （文章来源：新华财经） 本次数据中最突出的亮点是内需表现强劲，预计第三季度内需环比将激增1.5%，创下2012年初以来最 强劲季度增长。 经济复苏态势正日趋广泛，多个经济部门共同形成支撑，而非依赖个别领域的单独增长。随着异常大规 模资本支出项目（特别是飞机采购）的影响逐步消退，整体经济增长率在未来几个季度将有所放缓。 即便如此，剔除这些一次性因素后，当季基础增长率仍将保持在0.6%的健康水平，显示出经济内在韧 性。 新华财经北京11月28日电西太平洋银行预计澳大利亚经济在第三季度增长动能显著增强，澳大利亚第三 季度GDP将环比增长0.8%，年化增长率将升至2.3%，略高于澳洲联储最新的预测。 ...

西 太平洋银行预计澳大利亚经济在第三季度增长动能显著增强，澳大利亚第三季度GDP将环比增长 0.8%，年化增长率将升至2.3%，略高于澳洲联储最新的2.0%的预测。本次数据中最突出的亮点是内需 表现强劲，预计第三季度内需环比将激增1.5%，创下2012年初以来最强劲季度增长。经济复苏态势正 日趋广泛，多个经济部门共同形成支撑，而非依赖个别领域的单独增长。随着异常大规模资本支出项目 （特别是飞机采购）的影响逐步消退，整体经济增长率在未来几个季度将有所放缓。即便如此，剔除这 些一次性因素后，当季基础增长率仍将保持在0.6%的健康水平，显示出经济内在韧性。同时，预计生 产率将出现显著反弹，全年增幅达0.9%，这将推动名义单位劳动力成本增速放缓至约2.5%（按六个月 年化计算）。这对正在权衡通胀前景的澳洲联储而言将是一个积极信号。 ...